Compounded medications are customized according to the patients needs but are not reviewed or approved by the FDA for their safety or effectiveness
The most common GLP-1 side effects include mild to moderate nausea, diarrhea, occasional vomiting or upset stomach, constipation, stomach pain, temporary fatigue, increased heart rate, and headaches
Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or Data availability The datasets generated during and/or analysed during the current study are not publicly available due to the privacy of patient information, but can be requested from the corresponding author upon reasonable request
About one in nine adults globally has diabetes, with over 90 per cent of the cases living with type 2 diabetes and requiring effective management of their blood sugar levels
Regular review of weight loss progress, typically every three months, allows assessment of treatment response and consideration of whether continuation is appropriate according to NICE TA875, which recommends discontinuation if less than 5% weight loss is achieved after six months at the maintenance dose
I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment